World's Best Scientists 2026 revealed!
Award Badge
Immunology
Israel
2026

D-Index & Metrics

Immunology

D-Index
90
Citations
36757
World Ranking
1061
National Ranking
7

Medicine

D-Index
90
Citations
36749
World Ranking
12062
National Ranking
29

Ofer Mandelboim publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ofer Mandelboim sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 326 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ofer Mandelboim D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ofer Mandelboim sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Israel Leader Award
  • 2025 - Research.com Immunology in Israel Leader Award
  • 2023 - Research.com Immunology in Israel Leader Award
  • 2022 - Research.com Immunology in Israel Leader Award

Overview

Ofer Mandelboim is affiliated with the Hebrew University of Jerusalem in Israel. Their research mainly spans the fields of Medicine and Immunology and Microbiology, with significant contributions in Immunology, Oncology, Epidemiology, Molecular Biology, and Infectious Diseases.

Their work focuses on topics such as Immune Cell Function and Interaction, Cytomegalovirus and herpesvirus research, Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, Antimicrobial Peptides and Activities, Cancer Research and Treatments, and Viral-associated cancers and disorders.

Ofer Mandelboim has published extensively in several venues. The most frequent publication venues include Cancer Research, Nature Communications, bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Cellular and Infection Microbiology, and Frontiers in Immunology.

Significant recent papers authored or co-authored by Mandelboim include:

  • Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression, 2020, Nature Communications
  • Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System, 2020, Frontiers in Cellular and Infection Microbiology
  • Fusobacterium nucleatum and cancer, 2022, Periodontology 2000
  • Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity, 2020, Journal for ImmunoTherapy of Cancer
  • Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies, 2021, Cancers

The scientist has collaborated frequently with a number of peers, including Stipan Jonjić, Gilad Bachrach, T. Rovis, Batya Isaacson, and Yoav Charpak-Amikam.

Best Publications

  • The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

    Noa Stanietsky;Hrvoje Simic;Jurica Arapovic;Amir Toporik

  • Decidual NK cells regulate key developmental processes at the human fetal-maternal interface

    Jacob Hanna;Debra Goldman-Wohl;Yaron Hamani;Inbal Avraham

  • Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

    Chamutal Gur;Yara Ibrahim;Batya Isaacson;Rachel Yamin

  • Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

    Ofer Mandelboim;Niva Lieberman;Marianna Lev;Lada Paul

  • Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.

    Naoko Satoh-Takayama;Christian A.J. Vosshenrich;Christian A.J. Vosshenrich;Sarah Lesjean-Pottier;Sarah Lesjean-Pottier;Shinichiro Sawa

  • The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

    George B Cohen;George B Cohen;Rajesh T Gandhi;Daniel M Davis;Ofer Mandelboim

  • Characterization of the expression of MHC proteins in human embryonic stem cells

    Micha Drukker;Gil Katz;Achia Urbach;Maya Schuldiner

  • Host immune system gene targeting by a viral miRNA.

    Noam Stern-Ginossar;Naama Elefant;Albert Zimmermann;Dana G. Wolf

  • Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

    Roi Gazit;Raizy Gruda;Moran Elboim;Tal I Arnon

  • Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression

    Lishay Parhi;Tamar Alon-Maimon;Asaf Sol;Deborah Nejman

  • Recognition of viral hemagglutinins by NKp44 but not by NKp30

    Tal I. Arnon;Marina Lev;Gil Katz;Yehudit Chernobrov

  • Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells

    Daphna Nachmani;Noam Stern-Ginossar;Ronit Sarid;Ofer Mandelboim

  • Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

    Tal I Arnon;Hagit Achdout;Ofer Levi;Gal Markel

  • Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.

    Ofer Mandelboim;Hugh T. Reyburn;Mar Valés-Gómez;Laszlo Pazmany

  • The human natural killer cell immune synapse

    Daniel M. Davis;Isaac Chiu;Marlys Fassett;George B. Cohen

  • Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells

    Micha Drukker;Helena Katchman;Gil Katz;Smadar Even Tov Friedman

  • NK cells link obesity-induced adipose stress to inflammation and insulin resistance

    Felix M Wensveen;Vedrana Jelenčić;Sonja Valentić;Marko Šestan

  • Protection from natural killer cell-mediated lysis by HLA-G expression on target cells

    Laszlo Pazmany;Ofer Mandelboim;Mar Valés-Gómez;Daniel M. Davis

  • The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells.

    Hugh T. Reyburn;Ofer Mandelboim;Mar Valés-Gómez;Daniel M. Davis

  • CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells.

    Jacob Hanna;Ori Wald;Debra Goldman-Wohl;Diana Prus

Frequent Co-Authors

Angel Porgador
Angel Porgador Ben-Gurion University of the Negev
Gal Markel
Gal Markel Tel Aviv University
Jacob H. Hanna
Jacob H. Hanna Weizmann Institute of Science
Stipan Jonjić
Stipan Jonjić University of Rijeka
Jack L. Strominger
Jack L. Strominger Harvard University
Dana G. Wolf
Dana G. Wolf Hebrew University of Jerusalem
Daniel M. Davis
Daniel M. Davis University of Manchester
Michal Mandelboim
Michal Mandelboim Sheba Medical Center
Richard S. Blumberg
Richard S. Blumberg Brigham and Women's Hospital
Barbara Seliger
Barbara Seliger Martin Luther University Halle-Wittenberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare fields can open diverse career opportunities. Nursing programs, for example, offer accelerated paths to enter the healthcare sector quickly. Programs like the nurse practitioner accelerated program provide rigorous online learning designed for speed and efficiency, enabling students to advance into practitioner roles faster.

Individuals without prior nursing experience may find options such as 12-month accelerated nursing programs online for non nurses particularly valuable. These programs are tailored to help newcomers transition into nursing with a strong foundation and qualify for advanced practice opportunities.

For those seeking quicker entry points into nursing careers, the easiest accelerated nursing programs provide more accessible admissions criteria while maintaining quality education. Additionally, accredited practical nursing routes like the accredited lpn programs easy to get into offer foundational training programs that can lead to various patient care roles.

Exploring these related online degrees not only complements an Immunology background but also expands career pathways in the dynamic healthcare field.

Best Scientists Citing Ofer Mandelboim

Trending Scientists